Bulletin of the World Health Organization · 2015 · 26 citations · 5 references
PharmacyPharmaceutical PolicyPharmacoeconomicsCost-minimization AnalysisGlobal HealthHealth Technology AssessmentAccess To MedicinesEssential MedicinesMedication AffordabilityMedicine Selection PolicyPharmaceutical AssessmentPharmaceutical EconomicsDrug Cost AnalysisEssential Medicines AvailabilityEssential Medicines EconomicsEssential Medicines Selection CriteriaHigh-cost Drug SelectionPharmaceutical AccessPharmaceutical Cost AnalysisUniversal Access To Medicines
This year, the Expert Committee for the Selection and Use of Medicines will consider requests to include high-cost medicines for can -cer, hepatitis C, multidrug-resistant tu -berculosis and new oral anticoagulants on the model list. These applications challenge perceptions of essential medi -cines and raise questions about how to address issues of cost and affordability for countries when making decisions at the global level.Essential medicines are those that satisfy the priority health-care needs of the population.
5